Clinical Trial Update: Role Of Lactobacillus Reuteri DSM 17938 In The Non-Complicated Diverticular Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Lactobacillus reuteri DSM 17938 for non-complicated diverticular disease, including diverticulosis and diverticulitis; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diverticulitis
• Diverticulosis

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Casa Sollievo della Sofferenza IRCCS | Conditions: Diverticulosis, Diverticulitis | Phase 3 | Status: UNKNOWN